Focussing on brands with higher margin & growth prospects, says GSK Pharma

GlaxoSmithKline Pharmaceuticals (GSK Pharma) reported numbers for Q4. Revenue was flat while a pick-up in margins aided profit. A Vaidheesh, India MD of the company shared his views and outlook.